These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4146392)

  • 61. A new cephalosporin derivative (ST-21) orally administered in laboratory animals.
    Foresta P; Ramacci MT; De Witt P; Capitani N; Fanelli O
    Arzneimittelforschung; 1977; 27(4):819-23. PubMed ID: 577459
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Urinary excretion, blood levels, and toxicity in humans of the sodium salt of N-(5-nitro-2-furfurylidene)-1-aminohydantoin when given by the intramuscular and intravenous routes.
    MAZZA A; HECHT-LUCARI G
    Antibiot Chemother (Northfield); 1961 Jul; 11():434-7. PubMed ID: 13768698
    [No Abstract]   [Full Text] [Related]  

  • 63. The effects of a Lundh meal on the plasma concentration/time curve of ampicillin, amoxycillin, pivampicillin and cephalexin in normal subjects [proceedings].
    Parsons RL; Hossack GA; Paddock GM; Trounce JR
    Br J Clin Pharmacol; 1977 Jun; 4(3):406P-407P. PubMed ID: 901729
    [No Abstract]   [Full Text] [Related]  

  • 64. Cephalexin: effective oral antibiotic for coccal infections.
    Walker SH; Gonzales EP
    Md State Med J; 1971 Jan; 20(1):63-5. PubMed ID: 5141500
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmacokinetic study of cefadroxil following single and repeated doses.
    Brisson AM; Fourtillan JB
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():11-5. PubMed ID: 7142087
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of long-term treatment of urinary tract infection with a single dose in the evening.
    Sourander L; Saarimaa H
    Chemotherapy; 1975; 21(1):52-5. PubMed ID: 1149563
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics and intramuscular bioavailability of cefuroxime sodium in goats.
    ABO EL-SOOUD K; El-Banna HA; Hanafy MS; Goudah A
    Res Vet Sci; 2000 Dec; 69(3):219-24. PubMed ID: 11124092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Concentration of cephalexin in maxillary sinus mucosa and secretion.
    Kohonen A; Paavolainen M; Renkonen OV
    Ann Clin Res; 1975 Feb; 7(1):50-3. PubMed ID: 1155912
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-period double-dosing for simultaneous evaluation of intestinal absorption and hepatic disposition in a single conscious rat using cephalexin as test drug.
    Ito T; Yamaoka K; Nakagawa T
    J Pharm Pharmacol; 1997 Dec; 49(12):1189-94. PubMed ID: 9466341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacokinetics of cephalexin and cephradine in surgical patients].
    Iakovlev VP; Marshak AM; Klimova VS; Lur'e LA
    Antibiotiki; 1977 Aug; 22(8):739-42. PubMed ID: 334053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cephalexin: treatment of streptococcal pharyngitis.
    Azimi PH; Cramblett HG; Del rosario AJ; Kronfol H; Haynes RE; Hilty MD
    J Pediatr; 1972 Jun; 80(6):1042-5. PubMed ID: 4554591
    [No Abstract]   [Full Text] [Related]  

  • 72. [Renal accumulation of gentamicin in rabbits].
    Ishikawa K
    Jpn J Antibiot; 1983 Apr; 36(4):689-98. PubMed ID: 6876374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecularly imprinted solid phase extraction-pulsed elution-mass spectrometry for determination of cephalexin and alpha-aminocephalosporin antibiotics in human serum.
    Wu SG; Lai EP; Mayer PM
    J Pharm Biomed Anal; 2004 Nov; 36(3):483-90. PubMed ID: 15522521
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polarographic behavior of cephalexin and its determination in pharmaceuticals and human serum.
    Xu M; Ma H; Song J
    J Pharm Biomed Anal; 2004 Sep; 35(5):1075-81. PubMed ID: 15336354
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluorimetric determination of cephalexin.
    Barbhaiya RH; Turner P
    J Pharm Pharmacol; 1976 Oct; 28(10):791-2. PubMed ID: 10383
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.
    Rattie ES; Ravin LJ
    Antimicrob Agents Chemother; 1975 May; 7(5):606-13. PubMed ID: 1147591
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Statistical moments in pharmacokinetics.
    Yamaoka K; Nakagawa T; Uno T
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):547-58. PubMed ID: 731417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum and blood concentration of sodium cephalexin in man given single intramuscular and intravenous injections.
    Gower PE; Dash CH; O'Callaghan CH
    J Pharm Pharmacol; 1973 May; 25(5):376-81. PubMed ID: 4146392
    [No Abstract]   [Full Text] [Related]  

  • 79. Cephalexin: pharmacologic evaluation following oral and parenteral administration.
    Nicholas P; Meyers BR; Hirschman SZ
    J Clin Pharmacol; 1973; 13(11):463-8. PubMed ID: 4490669
    [No Abstract]   [Full Text] [Related]  

  • 80. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.